MicroVascular Tissues Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$4.11M
- Investors
-
1
MicroVascular Tissues General Information
Description
Developer of vascular products designed to address vascular deficiencies. The company specializes in stem cell research and human allograft tissue deployment services, providing researchers and physicians with products useful in biological vascular tissue implantation.
Contact Information
Website
www.mvtissues.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
- 6199 Cornerstone Court East
- Suite 109
- San Diego, CA 92121
- United States
+1 (858) 000-0000
MicroVascular Tissues Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 10-Mar-2023 | $4.11M | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC | 12-Sep-2018 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 28-Aug-2014 | $2.01M | $2.01M | 00.000 | Completed | Startup |
MicroVascular Tissues Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
| Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A | 3,445,076 | $0.001000 | $1.15 | $1.15 | 1x | $1.15 | 24.96% |
MicroVascular Tissues Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MicroVascular Tissues Patents
MicroVascular Tissues Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3086408-A1 | Compositions and methods for treating nerve injury | Pending | 08-Jan-2018 | 000000000 | |
| AU-2019205822-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | 000000000 | |
| EP-3737355-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | 000000000 | |
| US-20200353008-A1 | Compositions and methods for treating nerve injury | Pending | 08-Jan-2018 | 000000000 | |
| EP-3737355-A4 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | A61K9/0014 | 0 |
MicroVascular Tissues Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Glen Gong | President, Chief Executive Officer & Board Member | ||
| Dale Peterson Ph.D | Chief Technology Officer & Board Member |
MicroVascular Tissues Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dale Peterson Ph.D | MicroVascular Tissues | Chief Technology Officer & Board Member | 000 0000 |
| Kevin Oshasi | Self | Board Member | 000 0000 |
MicroVascular Tissues Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Pond Capital | Venture Capital | Minority | 000 0000 | 000000 0 |